Multiple Myeloma Hub‘s summary of the iStopMM key talks and posters at ASH 2021

Myeloma patients have an increased risk of severe COVID-19. MGUS, the precursor of myeloma, has previously been associated with an increased risk of infections, the

In May 2021 iStopMM reached an important milestone, with the publication of the first results of the screening study in its first article, “Iceland screens,

The Multiple Myelome Hub has provided a good summary of the key talks and posters from the iStopMM team at the 63rd American Society of